新版基本医保药品目录落地

Core Insights - The new basic medical insurance drug list has been officially implemented since January 1, 2026, with many insured individuals already purchasing newly added drugs from medical institutions [1] Group 1: New Drug Additions - A total of 114 new drugs have been added to the basic medical insurance drug list, with over half of these drugs already recorded in sales at medical institutions [1] - The drug Tirzepatide injection, used for treating adult type 2 diabetes, has been sold in 1,433 medical institutions [1] - The long-acting lipid-lowering drug Icosapent ethyl injection, which is administered once every six months, has been recorded in sales at 400 medical institutions [1] Group 2: Access and Information - Insured individuals can check the availability of insured drugs at medical institutions through the "National Medical Insurance Negotiated Drug Supply Institution List Inquiry" on the National Medical Insurance Service Platform [1]